Vcreate

Developer of T-cell receptor based therapies for the treatment of cancer

placeSan Carlos, California, United States calendar_todayFounded 2021 groups9 employees language vcreate.io

Innovation

3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 22 times.

YearFilings
20231
20241
20253

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon